Adiponectin levels have been shown to be lower in males, obesity, insulin resistance (including metabolic syndrome), type 2 diabetes mellitus, coronary artery disease and essential hypertension [15-18]. This evidence concerns the gene ADIPOQ and metabolic syndrome.